October 29, 2018

Titan Pharmaceuticals, the Trilogy

Titan Pharmaceuticals (TTNP) was in the news once again. After news hit the wires this morning that Canadian company Knight Therapeutics launched PROBUPHINE for treatment of opioid disorder, TTNP shares rallied over 13.2% higher pre-market. Knight has exclusive rights to distribute PROBUPHINE per an agreement with TTNP. However, TTNP shares retraced the overnight gains throughout the session. Here’s a recap of what happened.

about the author:

Mike Patton

Mike Patton took the leap into the markets beginning as a commodities broker in 2005, where he was responsible for identifying trading opportunities and executing trades on behalf of clients. After years as a broker he made the jump to education by joining the team at Trading Advantage, now Prosper Trading Academy.

Read Similar Articles

April 6, 2026

Q1 Earnings Season Preview: What To Expect

As we start a brand new quarter in 2026, it also resets the earnings cycle for companies to report their quarterly results — and I believe that Q1 Earnings Season could have a lot in store. Q4 earnings season at the start of the year gave traders a lot to process. It also set the […]

Read Article
April 3, 2026

March 2026 Jobs Report: The Good, Bad, & Unexpected

The March 2026 Jobs Report was among the most anticipated ones in recent memory. Right now, the economy is being shaped by a number of factors: These current circumstances — combined with February’s bad jobs report — had traders preparing for the worst. Fortunately, the March 2026 Jobs Report looked much better than expected…at least […]

Read Article
January 21, 2026

Could Penny Stocks Be The Big Play In 2026?

Written By: Howard Greenberg As everyday traders put their trading plans into action for 2026, penny stocks might not be on many of their radars. It’s totally understandable why penny stocks may not appeal to the more calculated seasoned traders. Their reputations for susceptibility to manipulation, extreme volatility, and low liquidity make them way too […]

Read Article

Read Similar Articles

May 17, 2026

The Week Ahead: Global Bond Selloff

Stock indexes continued their run higher this week with the S&P 500 and Nasdaq hitting record levels. But just as AI fueled the markets to record highs, spiking crude prices ignited global inflation fears. Markets tumbled on Friday as a jump in benchmark Treasury yields, reflecting surging energy prices and concerns about long-term inflation offered […]

Read Article
May 15, 2026

Mike Shorr Calls OUST Before It Popped 30 Percent

Have you ever heard of a stock called Ouster Inc. (OUST)? It’s a lidar sensor company that focuses on autonomous driving, robotics, and smart infrastructure. The stock is up over 47% in 2026. It’s a lesser-known name that usually flies under most trader’s radars (or in OUST’s case, lidar), so you probably missed its big […]

Read Article
May 15, 2026

Charlie Moon Nails The Dip In ASTS

On Thursday, Charlie Moon highlighted two setups in his daily watchlist that his AI Trade Finder spotted in AST SpaceMobile Inc. (ASTS): Charlie went with the “Buy the Dip” trade idea, and released a trade signal for it in his room. He wound up closing it that same day – for a 50%* win. Here’s […]

Read Article